Severe hypertension after initiation of rifapentine/isoniazid for latent tuberculosis in renal transplant candidates

Authors:

Abstract
Latent tuberculosis infection (LTBI) is not uncommon among renal transplant candidates (RTC) [1]. Rifapentine/isoniazid (RPT/INH) administered for 12 weeks is one of the first line treatments for LTBI [1] and we have recently showed that it is associated with higher completion rates than INH monotherapy for 9 months [2].